Cargando…

Definitive radiotherapy dose escalation with chemotherapy for treating non-metastatic oesophageal cancer

The locoregional failure rate remains high after concurrent chemoradiotherapy with standard-dose radiotherapy (RT, 50–50.4 Gy) for oesophageal cancer (EC). This retrospective study evaluated whether RT dose escalation was effective among 115 consecutive patients with non-metastatic EC (July 2003 to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Chao-Yueh, Su, Yu-Fu, Huang, Wen-Yen, Chao, Hsing-Lung, Lin, Kuen-Tze, Lin, Chun-Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110762/ https://www.ncbi.nlm.nih.gov/pubmed/30150679 http://dx.doi.org/10.1038/s41598-018-31302-y

Ejemplares similares

Dose escalation via brachytherapy boost for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy and combined chemotherapy
por: Chao, Hsing-Lung, et al.
Publicado: (2017)

Intensity modulated radiotherapy with concurrent chemotherapy for larynx preservation of advanced resectable hypopharyngeal cancer
por: Huang, Wen-Yen, et al.
Publicado: (2010)

Novel application of stereotactic ablative radiotherapy using CyberKnife(®) for early-stage renal cell carcinoma in patients with pre-existing chronic kidney disease: Initial clinical experiences
por: LO, CHENG-HSIANG, et al.
Publicado: (2014)

Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy
por: Pao, Tzu-Hui, et al.
Publicado: (2020)

Lower Urinary Tract Infection and Subsequent Risk of Prostate Cancer: A Nationwide Population-Based Cohort Study
por: Fan, Chao-Yueh, et al.
Publicado: (2017)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation
por: Carrington, Rhys, et al.
Publicado: (2015)

Long-Term Breast Cancer Patient Outcomes After Adjuvant Radiotherapy Using Intensity-Modulated Radiotherapy or Conventional Tangential Radiotherapy
por: Yang, Jen-Fu, et al.
Publicado: (2016)

Dose-escalated neoadjuvant chemoradiotherapy for locally advanced oesophageal or oesophagogastric junctional adenocarcinoma
por: Duque-Santana, Victor, et al.
Publicado: (2022)

Whether individualized dose escalation should be recommended for lymph nodes with different sizes in the definitive radiotherapy of cervical cancer?
por: Lv, Xiaojuan, et al.
Publicado: (2022)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

Ewing Sarcoma in Nepal Treated With Combined Chemotherapy and Definitive Radiotherapy
por: Jha, Anjani Kumar, et al.
Publicado: (2019)

Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy
por: Lo, Cheng-Hsiang, et al.
Publicado: (2017)

Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation
por: Hou, Wei-Hsien, et al.
Publicado: (2017)

Successful Treatment of Infantile Fibrosarcoma Spinal Metastasis by Chemotherapy and Stereotactic Hypofractionated Radiotherapy
por: Lo, Cheng-Hsiang, et al.
Publicado: (2013)

Dose-escalated radiotherapy improved survival for esophageal cancer patients with a clinical complete response after standard-dose radiotherapy with concurrent chemotherapy
por: Zhang, Wei, et al.
Publicado: (2018)

Efficacy of Dose-Escalated Radiotherapy for Recurrent Colorectal Cancer
por: Jo, Sunmi, et al.
Publicado: (2016)

Radiation dose escalation by simultaneous modulated accelerated radiotherapy combined with chemotherapy for esophageal cancer: a phase II study
por: Chen, Jianzhou, et al.
Publicado: (2016)

Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancer
por: Blazeby, J M, et al.
Publicado: (2014)

Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer
por: Cihoric, Nikola, et al.
Publicado: (2015)

Dose-Escalated Radiotherapy for the Treatment of Patients With Recurrent Colorectal Cancer
por: Kim, Hyung Jin, et al.
Publicado: (2016)

The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer
por: Devlin, Lynsey, et al.
Publicado: (2022)

Definitive Chemoradiation With Dose Escalation for Locally Advanced Gastric Cancer: Case Studies
por: Anthony, Michelle, et al.
Publicado: (2020)

Is radiotherapy after primary chemotherapy (RAPCHEM) on the right path to de-escalation?
por: Socha, Joanna, et al.
Publicado: (2023)

Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma
por: Pao, Tzu-Hui, et al.
Publicado: (2021)

Postoperative chemoradiotherapy in gastric cancer – a phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy
por: Jansen, E P M, et al.
Publicado: (2007)

Reduction of oesophageal toxicity with VMAT dose-sparing radiotherapy in thoracic metastatic spinal cord compression: A feasibility study
por: Gram, Vanja Remberg, et al.
Publicado: (2022)

Technical Assessment of an Automated Treatment Planning on Dose Escalation of Pancreas Stereotactic Body Radiotherapy
por: Wang, Shuo, et al.
Publicado: (2019)

Outcomes in patients with lacrimal gland carcinoma treated with definitive radiotherapy or eye-sparing surgery followed by adjuvant radiotherapy
por: Lin, Yun-Hsuan, et al.
Publicado: (2020)

Prognostic factors of dose-response relationship for nodal control in metastatic lymph nodes of cervical cancer patients undergoing definitive radiotherapy with concurrent chemotherapy
por: Lee, Won Hee, et al.
Publicado: (2022)

Individualized chemotherapy drug dose escalation in dogs with multicentric lymphoma
por: Siewert, Jacob M., et al.
Publicado: (2023)

Quantitative CT evaluation after two cycles of induction chemotherapy to predict prognosis of patients with locally advanced oesophageal squamous cell carcinoma before undergoing definitive chemoradiotherapy/radiotherapy
por: Yan, Shuo, et al.
Publicado: (2022)

Neural network dose prediction for rectal spacer stratification in dose‐escalated prostate radiotherapy
por: Thomas, Christopher, et al.
Publicado: (2022)

Image guided dose escalated prostate radiotherapy: still room to improve
por: Martin, Jarad M, et al.
Publicado: (2009)

Toxicity of dose-escalated radiotherapy up to 84 Gy for prostate cancer
por: Rosenbrock, Johannes, et al.
Publicado: (2023)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma
por: Crosby, T D L, et al.
Publicado: (2004)

Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis
por: Yang, Jen-Fu, et al.
Publicado: (2019)

The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy
por: Cox, Samantha, et al.
Publicado: (2017)

UGT1A1 Polymorphism for Irinotecan Dose Escalation in Patients with BRAF-Mutated Metastatic Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI
por: Hsieh, Yi-Chien, et al.
Publicado: (2021)

Skin Surface Dose for Whole Breast Radiotherapy Using Personalized Breast Holder: Comparison with Various Radiotherapy Techniques and Clinical Experiences
por: Chen, Chiu-Ping, et al.
Publicado: (2022)

Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer
por: Pao, Tzu-Hui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qvscfhlcg20r28758defev5p8o